Method of treating cancers with saha and pemetrexed

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/517 (2006.01) A61K 31/519 (2006.01) A61K 31/52 (2006.01)

Patent

CA 2636596

The present invention relates to a method of treating cancer in a subject in need thereof, by administering to a subject in need thereof a first amount of a histone deacetylase (HDAC) inhibitor or a pharmaceutically acceptable salt or hydrate thereof, and a second amount of an anti-cancer agent. The HDAC inhibitor and the anti-cancer agent may be administered to comprise therapeutically effective amounts. In various aspects, the effect of the HDAC inhibitor and the anti-cancer agent may be additive or synergistic.

La présente invention concerne un procédé de traitement anticancéreux d~un patient par administration d~une première quantité d~inhibiteur de la histone désacétylase (HDAC) ou d~un sel ou hydrate dudit inhibiteur pharmaceutiquement acceptable, puis d~une seconde quantité d~un agent anticancéreux. L~inhibiteur de HDAC et l~agent anticancéreux peuvent être administrés en des quantités efficaces sur le plan thérapeutique. Sous divers aspects, les effets de l~inhibiteur de HDAC et de l~agent anticancéreux peuvent se combiner de manière additive ou synergique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method of treating cancers with saha and pemetrexed does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating cancers with saha and pemetrexed, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating cancers with saha and pemetrexed will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2025298

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.